X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (193) 193
index medicus (108) 108
male (100) 100
hematology (98) 98
female (97) 97
adult (92) 92
middle aged (86) 86
oncology (76) 76
aged (61) 61
article (56) 56
prognosis (49) 49
leukemia (44) 44
cancer (40) 40
acute myeloid-leukemia (39) 39
mutation (38) 38
hemic and lymphatic diseases (37) 37
adolescent (36) 36
remission induction (36) 36
animals (35) 35
treatment outcome (35) 35
abridged index medicus (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
chemotherapy (29) 29
aged, 80 and over (27) 27
mice (27) 27
precursor cell lymphoblastic leukemia-lymphoma - genetics (27) 27
young adult (27) 27
acute lymphoblastic-leukemia (26) 26
leukemia, myeloid, acute - genetics (26) 26
survival analysis (26) 26
acute myeloid leukemia (24) 24
antineoplastic agents - therapeutic use (24) 24
expression (24) 24
acute myelogenous leukemia (23) 23
leukemia, myeloid, acute - drug therapy (23) 23
therapy (23) 23
disease-free survival (22) 22
immunophenotyping (22) 22
survival rate (22) 22
acute disease (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
cell biology (18) 18
follow-up studies (18) 18
genetic aspects (17) 17
research (17) 17
cell line, tumor (16) 16
cells (16) 16
acute lymphocytic leukemia (15) 15
acute promyelocytic leukemia (15) 15
aml (15) 15
recurrence (15) 15
chromosome aberrations (14) 14
karyotyping (14) 14
leukemia, myeloid, acute - pathology (14) 14
precursor cell lymphoblastic leukemia-lymphoma - pathology (14) 14
risk factors (14) 14
analysis (13) 13
base sequence (13) 13
clinical trials and observations (13) 13
cytarabine - administration & dosage (13) 13
differentiation (13) 13
drug resistance (13) 13
gene (13) 13
gene-expression (13) 13
molecular sequence data (13) 13
mutations (13) 13
child (12) 12
dna methylation (12) 12
flow cytometry (12) 12
gene expression (12) 12
health aspects (12) 12
myeloid neoplasia (12) 12
phenotype (12) 12
survival (12) 12
time factors (12) 12
daunorubicin - administration & dosage (11) 11
gene expression profiling (11) 11
gene expression regulation, leukemic (11) 11
group-b (11) 11
hematology, oncology and palliative medicine (11) 11
kaplan-meier estimate (11) 11
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (11) 11
daunorubicin (10) 10
fms-like tyrosine kinase 3 - genetics (10) 10
genetics & heredity (10) 10
genotype (10) 10
leukemia, myeloid, acute - mortality (10) 10
leukemia, promyelocytic, acute - drug therapy (10) 10
medicine, research & experimental (10) 10
neoplasms (10) 10
remission (10) 10
translocation, genetic (10) 10
acute nonlymphocytic leukemia (9) 9
apoptosis (9) 9
biochemistry & molecular biology (9) 9
bone marrow (9) 9
clinical trials (9) 9
cytarabine (9) 9
dna-binding proteins - genetics (9) 9
drug administration schedule (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Best practice & research. Clinical haematology, Volume 16, no. 4., 545-683
Book
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2012, Volume 2012, pp. 35 - 42
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1536 - 1537
Only the most specific main institutional affiliation is listed for Inside Blood authors, without indications of subdivisions, departments, parent... 
Flow Cytometry - methods | Leukemia, Myeloid, Acute - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Neoplasm, Residual - diagnosis | Leukemia, Myeloid, Acute - drug therapy | Female | Male | Neoplasm Recurrence, Local - epidemiology
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2015, Volume 15, pp. S2 - S6
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 12, pp. 1079 - 1089
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1249 - 1259
Patients with AML who were between 17 and 60 years of age were randomly assigned to receive induction therapy with the standard dose of daunorubicin or twice... 
CYTOSINE-ARABINOSIDE | MEDICINE, GENERAL & INTERNAL | ONCOLOGY-GROUP | INDUCTION CHEMOTHERAPY | ACUTE NONLYMPHOCYTIC LEUKEMIA | ACUTE MYELOGENOUS LEUKEMIA | ACUTE MYELOCYTIC-LEUKEMIA | GROUP-B | DAUNORUBICIN | REMISSION INDUCTION | UNTREATED ADULT PATIENTS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Myelomonocytic, Acute - drug therapy | Stem Cell Transplantation | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myelomonocytic, Acute - therapy | Adult | Female | Remission Induction - methods | Daunorubicin - administration & dosage | Leukemia, Myelomonocytic, Acute - genetics | Histone-Lysine N-Methyltransferase | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Combined Modality Therapy | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Myeloid-Lymphoid Leukemia Protein - genetics | Adolescent | Infusions, Intravenous | Mutation | Leukemia, Myelomonocytic, Acute - mortality | Anthracyclines | Usage | Daunorubicin | Young adults | Health aspects | Bone marrow | Chemotherapy | Consolidation | Kinases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
About 25% of young adults with ALL have Ph-like genotypes, which are associated with poor outcomes with conventional treatment. In this gene-expression study,... 
MEDICINE, GENERAL & INTERNAL | MODELS | B-CELL PRECURSOR | INHIBITOR THERAPY | IMATINIB | PEDIATRIC ACUTE LEUKEMIAS | GENE FUSION | EXPRESSION | ETV6-NTRK3 FUSION TRANSCRIPTS | CRLF2 | DELETION | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Adolescence | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Cell lines
Journal Article
Nature, ISSN 0028-0836, 10/2014, Volume 514, Issue 7523, pp. 513 - 517
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2013, Volume 19, Issue 3, pp. 368 - 371
Journal Article
Nature Medicine, ISSN 1078-8956, 2012, Volume 18, Issue 2, pp. 296 - 301
Journal Article